SIGHT SCIENCES, INC. Stock-Based Compensation
SIGHT SCIENCES, INC. (SGHT) reported Stock-Based Compensation of $5.82 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-05
- SIGHT SCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $2.96M, a 22.88% decline year-over-year.
- SIGHT SCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $2.85M, a 32.76% decline year-over-year.
- SIGHT SCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $2.55M, a 35.40% decline year-over-year.
- SIGHT SCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $2.42M, a 43.83% decline year-over-year.
- SIGHT SCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $13.05M, a 23.56% decline from fiscal 2024.
- SIGHT SCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $17.08M, a 17.12% increase from fiscal 2023.
- SIGHT SCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $14.58M, a 12.48% increase from fiscal 2022.
- SIGHT SCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $12.96M, a 155.03% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $5.82M 10-Q · filed 2026-08-05 | $8.37M derived: sum of 3 quarters · filed 2026-08-05 | $10.79M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $2.85M 10-Q · filed 2026-05-06 | $5.40M derived: sum of 2 quarters · filed 2026-05-06 | $7.82M derived: sum of 3 quarters · filed 2026-05-06 | $11.66M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $4.97M derived: sum of 2 quarters · filed 2026-03-04 | $8.81M derived: sum of 3 quarters · filed 2026-08-05 | $13.05M 10-K · filed 2026-03-04 |
| 2025-09-30 | $2.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $6.26M derived: sum of 2 quarters · filed 2026-08-05 | $10.51M 10-Q · filed 2025-11-06 | $14.45M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $3.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $8.09M 10-Q · filed 2026-08-05 | $12.03M derived: sum of 3 quarters · filed 2026-08-05 | $16.34M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $4.24M 10-Q · filed 2026-05-06 | $8.19M derived: sum of 2 quarters · filed 2026-05-06 | $12.50M derived: sum of 3 quarters · filed 2026-05-06 | $16.81M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $3.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $8.25M derived: sum of 2 quarters · filed 2026-03-04 | $12.57M derived: sum of 3 quarters · filed 2026-03-04 | $17.08M 10-K · filed 2026-03-04 |
| 2024-09-30 | $4.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $8.63M derived: sum of 2 quarters · filed 2025-11-06 | $13.13M 10-Q · filed 2025-11-06 | $16.59M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $4.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $8.82M 10-Q · filed 2025-08-07 | $12.28M derived: sum of 3 quarters · filed 2025-08-07 | $16.14M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $4.51M 10-Q · filed 2025-05-08 | $7.97M derived: sum of 2 quarters · filed 2025-05-08 | $11.82M derived: sum of 3 quarters · filed 2025-05-08 | $15.56M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $7.32M derived: sum of 2 quarters · filed 2025-03-07 | $11.06M derived: sum of 3 quarters · filed 2025-03-07 | $14.58M 10-K · filed 2025-03-07 |
| 2023-09-30 | $3.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $7.60M derived: sum of 2 quarters · filed 2024-11-07 | $11.12M 10-Q · filed 2024-11-07 | $14.36M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $3.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $7.26M 10-Q · filed 2024-08-02 | $10.50M derived: sum of 3 quarters · filed 2024-08-02 | $13.72M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $3.52M 10-Q · filed 2024-05-06 | $6.76M derived: sum of 2 quarters · filed 2024-05-06 | $9.98M derived: sum of 3 quarters · filed 2024-05-06 | $13.51M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $6.46M derived: sum of 2 quarters · filed 2024-03-13 | $9.99M derived: sum of 3 quarters · filed 2024-03-13 | $12.96M 10-K · filed 2024-03-13 |
| 2022-09-30 | $3.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $6.75M derived: sum of 2 quarters · filed 2023-11-07 | $9.73M 10-Q · filed 2023-11-07 | $11.71M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $3.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $6.51M 10-Q · filed 2023-08-07 | $8.48M derived: sum of 3 quarters · filed 2023-08-07 | $10.38M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $2.97M 10-Q · filed 2023-05-08 | $4.95M derived: sum of 2 quarters · filed 2023-05-08 | $6.85M derived: sum of 3 quarters · filed 2023-05-08 | $7.78M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $3.88M derived: sum of 2 quarters · filed 2023-03-16 | $4.81M derived: sum of 3 quarters · filed 2023-03-16 | $5.08M 10-K · filed 2023-03-16 |
| 2021-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $2.83M derived: sum of 2 quarters · filed 2022-11-10 | $3.11M 10-Q · filed 2022-11-10 | $3.31M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $931.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.21M 10-Q · filed 2022-08-11 | $1.41M derived: sum of 3 quarters · filed 2022-08-11 | $1.58M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $277.00K 10-Q · filed 2022-05-10 | $483.00K derived: sum of 2 quarters · filed 2022-05-10 | $648.00K derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | $206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $371.00K derived: sum of 2 quarters · filed 2022-03-24 | $497.00K 10-K · filed 2022-03-24 | |
| 2020-09-30 | $165.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $291.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $126.00K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |